|1.||Meinitzer, Andreas: 12 articles (09/2015 - 09/2010)|
|2.||März, Winfried: 11 articles (09/2015 - 09/2010)|
|3.||Pilz, Stefan: 11 articles (09/2015 - 09/2010)|
|4.||Kayacelebi, Arslan Arinc: 9 articles (09/2015 - 05/2014)|
|5.||Tsikas, Dimitrios: 9 articles (09/2015 - 05/2014)|
|6.||Drechsler, Christiane: 9 articles (07/2015 - 09/2010)|
|7.||Tomaschitz, Andreas: 8 articles (07/2015 - 04/2011)|
|8.||Wanner, Christoph: 8 articles (07/2015 - 09/2010)|
|9.||Schwedhelm, Edzard: 7 articles (09/2015 - 09/2013)|
|10.||Atzler, Dorothee: 7 articles (09/2015 - 09/2013)|
|1.||Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
|2.||Cardiovascular Diseases (Cardiovascular Disease)
01/01/2015 - "Animal experiments and clinical trials are needed to improve knowledge on the physiology of L-homoarginine and differentiate its role as marker and mediator in cardiovascular disease."
11/01/2014 - "Additional studies are needed to evaluate whether the regulation of plasma homoarginine could emerge as a novel therapeutic option to improve outcomes in cardiovascular disease."
02/01/2014 - "Previous studies in patient populations showed that low homoarginine levels indicate an increased risk of mortality and cardiovascular disease. "
09/01/2015 - "Homoarginine (hArg) is a non-essential amino acid that was identified as a risk marker for cardiovascular disease. "
01/01/2015 - "An increasing number of reports indicate that low levels of the endogenous amino acid L-homoarginine are linked to cardiovascular disease. "
11/01/1987 - "The present results suggest that in patients with hyperargininemia other factors such as arginine and its metabolites including GVA, GAA, ArgA and homoarginine may cause the neurological symptoms. "
12/27/2001 - "In the present study we investigated the in vitro effects of arginine, N-acetylarginine, argininic acid and homoarginine on some oxidative stress parameters in rat brain in the hope to identify a possible mechanism for the brain damage in hyperargininemia. "
08/14/1999 - "Considering that some GC are epileptogenic and cause a decrease in membrane fluidity and that Na+,K(+)-ATPase, a membrane-bound enzyme, is essential for cellular excitability and is decreased in experimental and human epilepsy, in the present study we determined the in vitro effects of Arg, N-acetylarginine (NAA), argininic acid (AA) and homoarginine (HA) on the activity of Na+,K(+)-ATPase in the synaptic plasma membrane from cerebral cortex of young rats in the hope to identify a possible mechanism for the brain damage in hyperargininemia. "
04/01/2003 - "Tissue accumulation of arginine (Arg), N-acetylarginine (NA), argininic acid (AA) and homoarginine (HA) occurs in hyperargininemia, an inborn error of the urea cycle. "
03/01/1991 - "The effects of arginine, homoarginine, alpha-keto-delta-guanidinovaleric acid and argininic acid (guanidino compounds that were found to be increased in hyperargininemia) were evaluated on responses to gamma-aminoburtyric acid (GABA) and glycine (Gly) on mouse neurons in primary dissociated cell culture. "
09/24/2013 - "Further validation in future trials may lead to therapeutic adjustments of homoarginine metabolism that alleviate stroke and other vascular disorders."
04/01/2011 - "Further studies are needed to explore the significance of homoarginine to risk stratification and therapeutic approaches in the prevention of strokes."
09/24/2013 - "Low homoarginine appears to be related to poor outcome after ischemic stroke. "
09/24/2013 - "Cerebral damage and neurological deficits in experimental stroke were increased in AGAT(-/-) mice and attenuated by homoarginine supplementation, whereas infarct size in GAMT(-/-) mice was decreased compared with controls. "
09/24/2013 - "Homoarginine was also independently associated with the National Institutes of Health Stroke Scale+age score and 30-day mortality after ischemic stroke (P<0.05; n=137). "
|5.||Kidney Diseases (Kidney Disease)
01/01/2013 - "We measured plasma homoarginine concentrations in baseline samples of the Mild to Moderate Kidney Disease (MMKD) Study, a prospective cohort study of 227 patients with CKD in Europe. "
01/01/2013 - "Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study."
01/01/2013 - "Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients."
01/01/2013 - "We aimed to investigate the relation between homoarginine, kidney function and progression of chronic kidney disease (CKD). "
07/01/2015 - "Prospective studies on the CVR associated with arginine/ADMA ratio and homoarginine in patients with moderate chronic kidney disease (CKD) are still scarce. "
|5.||N,N-dimethylarginine (asymmetric dimethylarginine)
|8.||Adenosine Triphosphatases (ATPase)
|9.||glycine amidinotransferase (arginine-glycine amidinotransferase)
|1.||Renal Dialysis (Hemodialysis)
|4.||Transplantation (Transplant Recipients)